Recently Updated Pages
47 - Who is at risk10,1416,18
Who is at risk?10,14–16,18
46 - Clinical relevance14,15
Clinical relevance14,15
45 - Time course
Time course 374 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 Time course The onse...
44 - Incidence and severity
Incidence and severity Depression and anxiety disorders CHAPTER 3 Antidepressant withdrawal sympt...
43 - Signs and symptoms
Signs and symptoms
42 - Antidepressant withdrawal symptoms
Antidepressant withdrawal symptoms
41 - References
References 372 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 References Horowitz ...
40 - General guidelines
General guidelines 366 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 Switching ant...
39 - Switching antidepressants
Switching antidepressants
38 - References
References 364 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 for 4–6 months after ...
37 - Summary
Summary
36 - Other treatments
Other treatments
35 - Maintenance treatment
Maintenance treatment Depression and anxiety disorders CHAPTER 3 Ketamine formulations Many of th...
34 - ECT
ECT
33 - Ketamine formulations
Ketamine formulations
32 - Acute treatment
Acute treatment 362 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 Psychotic depres...
31 - Psychotic depression
Psychotic depression
30 - References
References 360 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 References Berman RM...
29 - Adverse effects
Adverse effects 358 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 doses tested, in...
28 - Route of administration
Route of administration Depression and anxiety disorders CHAPTER 3 Ketamine Background Over the p...